Table 3.
Author | Year | Follow-up (months) | n | Age at ASA (years) | Pre | Post | Complications | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
NYHA | Rest grad (mmHg) | NYHA | Rest grad (mmHg) | Death at ASA (%) | Death at follow-up (%) | Death cardiac cause (%) | |||||
Seggewiss | 2007 | 58 | 100 | 53 | 2.8 | 76 | 1.6 | 0 | 1 | 4 | 2 |
Kwon | 2008 | 96 | 55 | 63 | 96% ≥3 | 70 | 17% ≥3 | 31 | 24 | 2 | |
Fernandes | 2008 | 55 | 579 | 54 | 2.8 | 77 | 1.4 | <10 | 9 | 4 | |
Kuhn | 2008 | 25 | 329 | 58 | 54 | 21 | 1.8 | 8.9 | 3 | ||
Lyne | 2010 | 141 | 12 | 49 | 2.7 | 70 | 1 | 3 | 0 | 24 | 16 |
Klopotowski | 2010 | 111 | 61 | 48 | 0 | 5 | 1.6 | ||||
Jensen | 2011 | 42 | 77 | 61 | 97% ≥3 | 60 | 9% ≥3 | 12 | 0 | 16 | 6.5 |
Nagueh | 2011 | 26 | 874 | 55 | 78% ≥3 | 70 | 4.5% ≥3 | 35 | 9.3 | 2.8 | |
Jensen | 2011 | 44 | 279 | 59 | 94% ≥3 | 58 | 21% ≥3 | 12 | 0.3 | 12.2 | |
Sorajja | 2012 | 68 | 177 | 64 | 100% ≥3 | 73 | 67% =1 | 11 | 1.1 | 14.7 | 2.8 |
Jensen | 2013 | 100 | 465 | 56 | 86% ≥3 | 60 | 8% ≥3 | 6 | 0 | 9 | 4 |
Veselka | 2014 | 3 | 436 | 57 | 2.8 | 88 | 1.6 | 21 | 0.2 | 0.7 |